Metabonomics study of intestinal transplantation using ultrahigh- performance liquid chromatography time-of-flight mass spectrometry

Digestion

Volumn 77, Issue 2, 2008, Pages 122-130

  Li, Qiurong ^a   Zhang, Qiang ^a   Xu, Guowang ^b   Yin, Peiyuan ^b   Li, Ning ^a   Li, Jieshou ^a  

^a JINLING HOSPITAL   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Biomarker; Intestinal transplantation; Metabonomics; Ultrahigh performance liquid chromatography time of flight mass spectrometry

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHENYLALANINE; TRYPTOPHAN;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE TRANSPLANTATION; MALE; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SCREENING; TIME OF FLIGHT MASS SPECTROMETRY;

ADOLESCENT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; HUMANS; INTESTINE, SMALL; MALE; SHORT BOWEL SYNDROME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 42349101536     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000123842     Document Type: Article

References (28)

1. Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK: NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993;43:234-245.
2. Wishart DS: Metabolomics: the principles and potential applications to transplantation. Am J Transplant 2005;5:2814-2820.
3. Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J: A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 2005;130:844-849.
4. Wilson ID, Plumb R, Granger J, Major H, Williams R, Lenz EM: HPLC-MS-based methods for the study of metabonomics. J Chromatogr B 2005;817:67-76.
5. Kenny LC, Dunn WB, Ellis DI, Myers J, Baker PN, GOPEC Consortium, Kell DB: Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics 2005;1:227-234.
6. Schauer N, Steinhauser D, Strelkov S, Schomburg D, Allison G, Moritz T, Lundgren K, Roessner-Tunali U, Forbes MG, Willmitzer L, Fernie AR, Kopka J: GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Lett 2005;579:1332-1337.
7. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ: A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003,75:1241-1248.
8. Yin P, Zhao X, Li Q, Wang J, Li J, Xu G: Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 2006;5:2135-2143.
9. Salaman JR: Monitoring of rejection in renal transplantation. Immunol Lett 1991;29:139-142.
10. 3. Anal Biochem 2002;301:1-7.
11. Hauet T, Baumert H, Gibelin H, Hameury F, Goujon JM, Carretier M, Eugene M: Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 2000;41:280-291.
12. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU: H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005;67:1142-1151.
13. Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tome D: Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993;65:433-439.
14. Al Banchaabouchi M, Marescau B, D'Hooge R, Engelborghs S, De Deyn PP: Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice. Amino Acids 2000;18:265-277.
15. Al Banchaabouchi M, Marescau B, D'Hooge R, Van Mark E, Van Daele A, Levillan O, De Deyn PP: Biochemical and histopathological changes in nephrectomized mice. Metabolism 1998;47:355-361.
16. Dedeoglu IO, Feld LG: Decreased urinary excretion of nitric oxide in acute rejection episodes in pediatric renal allograft recipients. Transplantation 1996;62:1936-1968.
17. Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P: Subclinical rejection - a potential surrogate marker for chronic rejection - may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000;5:44-49.
18. Silva MA, Richards DA, Bramhall SR, Adams DH, Mirza DF, Murphy N: A study of the metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation. Transplantation 2005;79:828-835.
19. Gibelin H, Eugene M, Hebrard W, Henry C, Carretier M, Hauet T: A new approach to the evaluation of liver graft function by nuclear magnetic resonance spectroscopy: a comparative study between Euro-Collins and University of Wisconsin solutions. Clin Chem Lab Med 2000;38:1133-1136.
20. Eugene M, Le Moyec L, de Certaines J, Desruennes M, Le Rumeur E, Fraysse JB, Cabrol C: Lipoproteins in heart transplantation: proton magnetic resonance spectroscopy of plasma. Magn Reson Med 1991;18:93-101.
21. Mouly-Bandini A, Vion-Dury J, Viout P, Sciaky M, Mesana T, Cozzone PJ: Detection of acute cardiac rejection by high resolution proton magnetic resonance spectroscopy of plasma. MAGMA 2000;11:27-32.
22. Martin-Sanz P, Olmedilla L, Dulin E, Casado M, Callejas NA, Pérez-Peña J, Garutti I, Sanz J, Calleja J, Barrigón S, Boscá L: Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function. Liver Transpl 2003;9:40-48.
23. 1H-NMR spectroscopy in assessment of liver graft dysfunction. NMR Biomed 2003;16:185-188.
24. Melendez HV, Ahmadi D, Parkes HG, Rela M, Murphy G, Heaton N: Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation 2001;72:855-860.
25. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H: Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun 1990;168:301-305.
26. Ma H, Wang JH, Wang J, Li YS, Li JS: Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant 2007;11:173-179.
27. Blaut M, Clavel T: Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 2007;137:751S-755S.
28. Vasan RS: Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006;113:2335-2362.